Gewinn- und Verlustrechnung von Carpenter Technology Corporation

Carpenter Technology NYSE: CRS said fiscal 2026 marked another record year for earnings, while the company continues to pursue a capacity expansion intended to support demand from aerospace and defense customers.

Tompkins Financial Corp lowered its holdings in Carpenter Technology Corporation (NYSE: CRS) by 98.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115 shares of the basic materials company's stock after selling 6,806 shares during the quarter. Tompkins Financial

Poolbeg Pharma PLC (AIM:POLB), the clinical-stage biopharmaceutical company, has secured a South Korean patent for POLB 001 to prevent cytokine release syndrome (CRS) induced by cancer immunotherapy. CRS is a potentially serious complication of a range of cancer immunotherapies.

[url="]Genmab A/S[/url](Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced today positive topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed tr

AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients wi

PHILADELPHIA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, October 22, 2026 at 10:00 a.m. ET to discuss the results of operations for the first quarter of fiscal year 2027, ended September 30, 2026. The call and webcast will follow the release of first quarter fiscal 2027 financial results before the market opens on Thursday, October 22, 2026.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 500 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum and is suitable for investors in the accumulation phase.

The heavy selling pressure might have exhausted for Carpenter (CRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CRS sees strong aerospace demand and rising bookings supporting fiscal 2027 growth, with capacity expansion set to aid longer-term gains.